Table 2.
Evaluation of bladder management, previous genitourinary surgery, and recurrent urinary tract infections in the enrolled population.
| ID | Bladder management | History of GU surgeries | rUTIs |
|---|---|---|---|
| 1 | CIC + MRA | Urethral bulking BTX injections into the detrusor wall | No |
| 2 | CIC | No | Yes |
| 3 | IDC | TUCL | Yes |
| 4 | IDC + MRA | Urethral fistulectomies | Yes |
| 5 | Reflex voiding | No | Yes |
| 6 | CIC + MRA | Endoscopic urethrotomy TUCL | No |
| 7 | CIC + MRA | Urethral fistulectomies BTX injections into the detrusor wall | Yes |
| 8 | Reflex voiding | Ureterocelectomy Urethroplasty | Yes |
| 9 | IDC | No | Yes |
| 10 | CIC + MRA | BTX injections into the detrusor wall | Yes |
| Cases: 10 | CIC: 5/10 (50%) | Urethral surgery: 5/10 (50%) | No: 2/10 (20%) |
| IDC: 3/10 (30%) | BTX injections into the detrusor wall: 3/10 (30%) | Yes: 8/10 (80%) | |
| MRA: 5/10 (50%) | TUCL: 2/10 (20%) | ||
| RV: 2/10 (20%) | No: 3/10 (30%) |
BTX botulinum toxin, CIC clean intermittent catheterization, GU genitourinary, IDC indwelling urinary catheter, MRA muscarinic receptor antagonist, rUTIs recurrent urinary tract infections, RV reflex voiding, TUCL transurethral cystolithotripsy.